Generative Biology, Human Ingenuity, Faster Breakthroughs
ACCELERATING NEW POSSIBILITIES IN DRUG DISCOVERY AND DEVELOPMENT

Superluminal Medicines is a generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. The company’s platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure.

Our predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect.

infographic

Careers

Join us to accelerate new possibilities in drug discovery.
» View our open jobs

Our Team

Yamina A. BerchicheYamina A. Berchiche
LinkedInYamina A. Berchiche
Senior Director, Biology
Ryan BloomRyan Bloom
Ryan Bloom
VP, Business Development
Jiming ChenJiming Chen
LinkedInJiming Chen
Computational Chemist
Cony D'CruzCony D'Cruz
Cony D'Cruz
Co-founder & CEO
Mark FitzgeraldMark Fitzgerald
Mark Fitzgerald
Director, Medicinal Chemistry
Colin GauvinColin Gauvin
Colin Gauvin
Scientist - Structural Biology
Nathan GenungNathan Genung
Nathan Genung
Director, Medicinal Chemistry
Mehdi JokarMehdi Jokar
LinkedInMehdi Jokar
Machine Learning Engineer
Charles NorsigianCharles Norsigian
Charles Norsigian
Sr. Data Science Engineer
Chris OalmannChris Oalmann
Chris Oalmann
AVP, Head of Medicinal Chemistry
Marek OrzechowskiMarek Orzechowski
LinkedInMarek Orzechowski
Senior Director, Computational Chemistry
Min-Sun ParkMin-Sun Park
LinkedInMin-Sun Park
Senior Computational Chemist
Sokhom PinSokhom Pin
Sokhom Pin
VP, Biology
Murco Ringnalda Murco Ringnalda
LinkedInMurco Ringnalda
SVP, Head of Operations
Alix RouaultAlix Rouault
Alix Rouault
Scientist - Biology
Kayla TiftKayla Tift
LinkedInKayla Tift
Business Operations Manager
Zhonghui XuZhonghui Xu
LinkedInZhonghui Xu
Senior Machine Learning Engineer
Ajay YekkiralaAjay Yekkirala
LinkedInAjay Yekkirala
Co-founder & SVP, Head of Discovery
Yang-Ming ZhuYang-Ming Zhu
LinkedInYang-Ming Zhu
SVP, Head of Engineering
RA Capital
Insight
NVIDIA
Catalio
Lilly
Gaingels
Cooley

Publications

Are Deep Learning Structural Models Sufficiently Accurate for Free-Energy Calculations? Application of FEP+ to AlphaFold2-Predicted Structures » FULL ARTICLE
Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures » FULL ARTICLE
Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks » FULL ARTICLE
Superluminal Medicines, Inc.
15 Necco St.
Lilly Gateway Labs, 4th Floor
Boston, MA 02210
(781) SUN - 8484